Business Context and Reporting Period
Company: InspireMD, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: April 3, 2026
Reporting Period: Event-based report regarding corporate actions taken on April 3, 2026.
Key Financial Metrics and Capital Structure
This filing does not contain standard financial performance metrics such as revenue, profit, cash flow, or operating margins. The primary financial data relates to capital raising activities:
- New Offering Capacity: Up to $75,000,000 in common stock shares.
- Sales Agent Commission: Up to 3.0% of gross proceeds.
- Prior Offering Activity: 1,361,519 shares sold under the terminated prior agreement.
- Debt and Liquidity: The filing text does not provide specific values for current debt levels or liquidity positions.
Material Changes
The filing discloses two significant material changes regarding the company's equity distribution strategy:
- Entry into New Agreement: On April 3, 2026, the Company entered into a new Equity Distribution Agreement with BTIG, LLC to sell up to $75,000,000 of common stock via "at the market" offerings.
- Termination of Prior Agreement: Effective April 3, 2026, the Company terminated its previous Equity Distribution Agreement with Piper Sandler & Co. No termination penalties were incurred.
Guidance, Outlook, and Management Commentary
Use of Proceeds: The Company intends to use net proceeds from the new offering for operations, including research and development, sales and marketing, working capital, and general corporate purposes.
Outlook: The Company cannot provide assurances that it will issue any shares under the new agreement. Sales will be conducted based on the Company's instructions and market conditions.
Risks and Contingencies: The filing notes standard risks associated with "at the market" offerings, including the uncertainty of share issuance and the obligation to pay commissions on sold shares.
Investor Verification Checklist
- Verify the current market price of InspireMD common stock (NSPR) to assess potential dilution from the $75,000,000 offering capacity.
- Review the full text of the Equity Distribution Agreement (Exhibit 10.1) for specific price limits or conditions imposed by the Company.
- Confirm the Company's current cash position and burn rate to understand the urgency of the capital raise.
- Check subsequent filings to determine if any shares have actually been sold under the new BTIG agreement.